Based on the Pulmonx Corp stock forecast from 4 analysts, the average analyst target price for Pulmonx Corp is USD 15.00 over the next 12 months. Pulmonx Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Pulmonx Corp is Very Bearish, which is based on 0 positive signals and 3 negative signals. At the last closing, Pulmonx Corp’s stock price was USD 7.52. Pulmonx Corp’s stock price has changed by +1.21% over the past week, -18.35% over the past month and -39.31% over the last year.
No recent analyst target price found for Pulmonx Corp
No recent average analyst rating found for Pulmonx Corp
Company Overview Pulmonx Corp
ProLung, Inc., a medical technology company, develops, markets, and sells precision predictive analytical medical devices specializing in lung cancer in the United States. It offers ProLung system, which consists of various medical grade components comprising a probe, scanner, tower, monitor, and keyboard; and ProLung test kits that assess the risk of malignancy in lung nodules found in the chest by a computed tomography scan, which is used for the early detection of lung cancer. The company was formerly known as Fresh Medical Laboratories, Inc. and changed its name to ProLung, Inc. in April 2017. ProLung, Inc. was founded in 2004 and is headquartered in Salt Lake City, Utah. Read Less
ProLung, Inc., a medical technology company, develops, markets, and sells precision predictive analytical medical devices specializing in lung cancer in the United States. It offers ProLung system, which consists of various medical grade components comprising a probe, scanner, to...Read More
Frequently Asked Questions About Pulmonx Corp (LUNG) Stock
Based on ratings from 4 analysts Pulmonx Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 5 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on LUNG's stock to indicate if its a good dividend stock.
Based on targets from 4 analysts, the average taret price for LUNG is USD 15.00 over the next 12 months. The maximum analyst target price is USD 17 while the minimum anlayst target price is USD 12.
Unfortunately we do not have enough data on LUNG's stock to indicate if its overvalued.
The last closing price of LUNG's stock was USD 7.52.
Unfortunately we do not currently have any market capitalization data for LUNG's stock.
Based on targets from 4 analysts, the average taret price for LUNG is projected at USD 15.00 over the next 12 months.
This means that LUNG's stock price may go up by +99.47% over the next 12 months.
We can't find any ETFs which contains Pulmonx Corp's stock.
As per our most recent records Pulmonx Corp has 0 Employees.
Sorry we do not have any infomation available on Pulmonx Corp's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for LUNG !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
